Nuvation Bio Inc. Fair Value Adjustment of Warrants
Nuvation Bio Inc. (NUVB) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- Nuvation Bio Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
- Nuvation Bio Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$2.87M, a 481.49% decline year-over-year.
- Nuvation Bio Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $1.13M, a 1.57% decline year-over-year.
- Nuvation Bio Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$612.00K.
- Nuvation Bio Inc. fair value adjustment of warrants for fiscal 2025 was $812.00K, a 13.25% decline from fiscal 2024.
- Nuvation Bio Inc. fair value adjustment of warrants for fiscal 2024 was $936.00K.
- Nuvation Bio Inc. fair value adjustment of warrants for fiscal 2023 was -$497.00K.
- Nuvation Bio Inc. fair value adjustment of warrants for fiscal 2022 was -$10.19M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 8 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | -$2.87M 10-Q · filed 2026-08-06 | -$1.74M derived: sum of 3 quarters · filed 2026-08-06 | -$2.35M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$2.87M 10-Q · filed 2026-05-04 | -$1.74M derived: sum of 2 quarters · filed 2026-05-04 | -$2.35M derived: sum of 3 quarters · filed 2026-05-04 | -$2.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $515.00K derived: sum of 2 quarters · filed 2026-03-02 | $61.00K derived: sum of 3 quarters · filed 2026-08-06 | $812.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | -$612.00K 10-Q · filed 2025-11-03 | -$1.07M derived: sum of 2 quarters · filed 2026-08-06 | -$315.00K 10-Q · filed 2025-11-03 | $830.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$454.00K 10-Q · filed 2026-08-06 | $297.00K 10-Q · filed 2026-08-06 | $1.44M derived: sum of 3 quarters · filed 2026-08-06 | $909.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $751.00K 10-Q · filed 2026-05-04 | $1.90M derived: sum of 2 quarters · filed 2026-05-04 | $1.36M derived: sum of 3 quarters · filed 2026-05-04 | $228.00K derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $612.00K derived: sum of 2 quarters · filed 2026-03-02 | -$523.00K derived: sum of 3 quarters · filed 2026-03-02 | $936.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | -$533.00K 10-Q · filed 2025-11-03 | -$1.67M derived: sum of 2 quarters · filed 2025-11-03 | -$209.00K 10-Q · filed 2025-11-03 | -$446.00K derived: sum of 4 quarters · filed 2025-11-03 | |
| 2024-06-30 | -$1.14M 10-Q · filed 2025-08-07 | $324.00K 10-Q · filed 2025-08-07 | $87.00K derived: sum of 3 quarters · filed 2025-08-07 | -$296.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $1.46M 10-Q · filed 2025-05-07 | $1.22M derived: sum of 2 quarters · filed 2025-05-07 | $839.00K derived: sum of 3 quarters · filed 2025-05-07 | $1.10M derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$620.00K derived: sum of 2 quarters · filed 2025-03-06 | -$355.00K derived: sum of 3 quarters · filed 2025-03-06 | -$497.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$383.00K 10-Q · filed 2024-11-06 | -$118.00K derived: sum of 2 quarters · filed 2024-11-06 | -$260.00K 10-Q · filed 2024-11-06 | -$581.00K derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $265.00K 10-Q · filed 2024-08-05 | $123.00K 10-Q · filed 2024-08-05 | -$198.00K derived: sum of 3 quarters · filed 2024-08-05 | -$660.00K derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | -$142.00K 10-Q · filed 2024-05-14 | -$463.00K derived: sum of 2 quarters · filed 2024-05-14 | -$925.00K derived: sum of 3 quarters · filed 2024-05-14 | -$4.00M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$783.00K derived: sum of 2 quarters · filed 2024-02-29 | -$3.86M derived: sum of 3 quarters · filed 2024-02-29 | -$10.19M 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$462.00K 10-Q · filed 2023-11-02 | -$3.54M derived: sum of 2 quarters · filed 2023-11-02 | -$9.87M 10-Q · filed 2023-11-02 | -$13.77M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$3.08M 10-Q · filed 2023-08-03 | -$9.40M 10-Q · filed 2023-08-03 | -$13.30M derived: sum of 3 quarters · filed 2023-08-03 | -$13.43M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$6.32M 10-Q · filed 2023-05-04 | -$10.22M derived: sum of 2 quarters · filed 2023-05-04 | -$10.35M derived: sum of 3 quarters · filed 2023-05-04 | -$10.85M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$4.02M derived: sum of 2 quarters · filed 2023-03-15 | -$4.52M derived: sum of 3 quarters · filed 2023-03-15 | -$4.23M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$125.00K 10-Q · filed 2022-11-03 | -$625.00K derived: sum of 2 quarters · filed 2022-11-03 | -$332.00K 10-Q · filed 2022-11-03 | -$332.00K derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$500.00K 10-Q · filed 2022-08-04 | -$207.00K 10-Q · filed 2022-08-04 | -$207.00K derived: sum of 3 quarters · filed 2022-08-04 | -$207.00K derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $293.00K 10-Q · filed 2022-05-09 | $293.00K derived: sum of 2 quarters · filed 2022-05-09 | $293.00K derived: sum of 3 quarters · filed 2022-05-09 | $293.00K derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $8.02M 10-K/A · filed 2021-05-21 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |